{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:23Z","timestamp":1786975943962,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd010854","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000}}],"reference-count":58,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010854.pub2","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T14:32:36Z","timestamp":1426861956000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Add-back therapy with GnRH analogues for uterine fibroids"],"prefix":"10.1002","volume":"2015","author":[{"given":"Rafael M","family":"Moroni","sequence":"first","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington P","family":"Martins","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui A","family":"Ferriani","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S","family":"Vieira","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina O","family":"Nastri","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Candido Dos Reis","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gustavo","family":"Brito","sequence":"additional","affiliation":[{"name":"University of Sao Paulo; Department of Obstetrics and Gynecology, Medical School of Ribeirao Preto; Avenida Bandeirantes, 3900, 8th floor ? Monte Alegre Ribeirao Preto Ribeirao Preto Brazil 14049-900"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD010854.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0015-0282(03)02166-6","article-title":"Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: A prospective, randomized, double-blind, placebo-controlled, crossover trial","volume":"80","author":"Carr","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD010854.pub2-BIB0002|cit2","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double blind, placebo- controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010854.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0015-0282(02)03551-3","article-title":"Treatment with the GnRH agonist (GnRHa) deslorelin (D) and low-dose add-back estradiol (E2) is effective in reducing pain, bleeding and uterine volume(UV) while maintaining bone mineral density (BMD) in women with symptomatic uterine fibroids (UF)","volume":"78","author":"Daniels","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD010854.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsgi.2006.02.008","article-title":"Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor","volume":"13","author":"Falco","year":"2006","journal-title":"Journal of the Society for Gynecologic Investigation"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.pgp.0000163848.29506.67","article-title":"Expression of proliferating cell nuclear antigen and bcl-2 during a pseudomenopausal state induced by presurgical treatment of uterine leiomyomas with gonadotropin-releasing hormone analogues plus tibolone","volume":"24","author":"Falco","year":"2005","journal-title":"International Journal of Gynecological Pathology"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2004.10.008","article-title":"Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern","volume":"70","author":"Lieto","year":"2005","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0007|cit7","first-page":"S19","article-title":"Add-back therapy of uterine fibroids with tibolone and goserelin","volume":"86","author":"Espejo","year":"1999","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(16)59763-5","article-title":"A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri","volume":"49","author":"Friedman","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0009|cit9","first-page":"222","article-title":"The effects of add-back therapy with tibolone on myoma uteri","volume":"29","author":"Gocmen","year":"2002","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010854.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/humrep\/14.Suppl_3.273-a","article-title":"The effect of add-back treatment with tibolone on patients with myoma uteri treated with triptorelin","volume":"14","author":"Gocmen","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0012|cit11","unstructured":"Morris EP A placebo controlled, randomised, double blind study of tibolone as \"add-back therapy\" in conjunction with a gonadotrophin-releasing hormone analogue in the treatment of uterine fibroids Thesis - Doctor of Medicine - University of London 2001"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0011|cit12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2007.02.064","article-title":"Efficacy of tibolone as \"add-back therapy\" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids","volume":"89","author":"Morris","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD010854.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/09513599909167584","article-title":"Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata","volume":"13","author":"Nakayama","year":"1999","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0015-0282(98)00128-9","article-title":"A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata","volume":"70","author":"Palomba","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0015-0282(00)01676-9","article-title":"Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy","volume":"75","author":"Palomba","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD010854.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1210\/jc.2002-020780","article-title":"Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism","volume":"87","author":"Palomba","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.fertnstert.2003.11.061","article-title":"Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life","volume":"82","author":"Palomba","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD010854.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/humrep\/17.12.3213","article-title":"Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial","volume":"17","author":"Palomba","year":"2002","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2007.05.061","article-title":"Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas","volume":"90","author":"Palomba","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD010854.pub2-BIB0020|cit20","first-page":"2545","article-title":"'Add-back' estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri","volume":"81","author":"Sherwin","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD010854.pub2-BIB0021|cit21","first-page":"3202","article-title":"Efficacy of ipriflavone in preventing adverse effects of leuprolide","volume":"86","author":"Somekawa","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0022|cit22","first-page":"13","article-title":"Bone mass changes in patients treated for 6 months with GnRH analogues associated with a low dose of ERT as 'add-back' therapy.","volume":"7","author":"Alfonso","year":"1998","journal-title":"Archivio di Ostetricia e Ginecologia"},{"issue":"4","key":"10.1002\/14651858.CD010854.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0020-7292(90)90520-U","article-title":"Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata","volume":"33","author":"Benagiano","year":"1990","journal-title":"International Journal of Gynaecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/humrep\/12.3.436","article-title":"Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: Effects on bone density and patient acceptability","volume":"12","author":"Caird","year":"1997","journal-title":"Human Reproduction"},{"issue":"9","key":"10.1002\/14651858.CD010854.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/oxfordjournals.humrep.a138762","article-title":"Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen\u2014progestin or progestin \u2018add-back\u2019 for 2 years","volume":"9","author":"Friedman","year":"1994","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0020-7292(94)02262-W","article-title":"GnRHa and steroid add-back therapy for uterine myoma","volume":"48","author":"Ishimaru","year":"1995","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD010854.pub2-BIB0027|cit27","first-page":"25","article-title":"The use of Ovestin to overcome the side effects of treatment with GnRH agonists (Zoladex)","volume":"37","author":"Ivanov","year":"1998","journal-title":"Akusherstvo i ginekologiia"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-0528.1992.tb13533.x","article-title":"Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy","volume":"99 Suppl 7","author":"Maheux","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9378(96)70258-2","article-title":"A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment","volume":"175","author":"Mukherjee","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0015-0282(16)57729-2","article-title":"Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri","volume":"64","author":"Scialli","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD010854.pub2-BIB0032|cit32","first-page":"2700","article-title":"Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide","volume":"84","author":"Somekawa","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0033|cit33","first-page":"21","article-title":"Possible role of LH-RH analog and oral contraceptive binding in the treatment of uterine leiomyoma","volume":"16","author":"Ingrassia","year":"1994","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0034|cit34","first-page":"not informed","article-title":"Bone mineral density evaluation in women treated with GnRH agonists for leiomyomata and receiving Mercilon \"add-back\" therapy","volume":"7","author":"Opala","year":"1997","journal-title":"Osteoporosis International"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0035|cit35","first-page":"202","article-title":"Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25\u201340 years","volume":"79","author":"Borgfeldt","year":"2000","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1074-3804(05)60075-8","article-title":"Comparative study of different dosages of goserelin in size reduction of myomatous uteri","volume":"11","author":"Bozzini","year":"2004","journal-title":"The Journal of the American Association of Gynecologic Laparoscopists"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0037|cit37","first-page":"1309","article-title":"Lower tract urinary symptoms in patients with uterine myomas","volume":"22 Suppl 2","author":"Cheung","year":"2011","journal-title":"International Urogynecology Journal and Pelvic Floor Dysfunction"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0038|cit38","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD010854.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-2243(90)90096-J","article-title":"Luteinizing hormone-releasing hormone analogue therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot","volume":"37","author":"Costantini","year":"1990","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Day Baird","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"8","key":"10.1002\/14651858.CD010854.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environmental Health Perspectives"},{"issue":"4","key":"10.1002\/14651858.CD010854.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(16)59464-3","article-title":"Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist","volume":"48","author":"Friedman","year":"1987","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD010854.pub2-BIB0043|cit43","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study","volume":"77","author":"Friedman","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0044|cit44","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD010854.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD010854.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0047|cit47","article-title":"Fibroids (uterine myomatosis, leiomyomas)","volume":"pii:0814","author":"Lethaby","year":"2011","journal-title":"Clinical Evidence (Online)"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0015-0282(03)02207-6","article-title":"Uterine fibroids and gynecologic pain symptoms in a population-based study","volume":"80","author":"Lippman","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0950-3552(98)80060-6","article-title":"Clinical presentation of uterine fibroids","volume":"12","author":"Lumsden","year":"1998","journal-title":"Bailli\u00e8re's Clinical Obstetrics and Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD010854.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0015-0282(99)00366-0","article-title":"Long term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass and lipid profiles","volume":"72","author":"Palomba","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD010854.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/humrep\/deh296","article-title":"Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.","volume":"19","author":"Palomba","year":"2004","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-199651020-00009","article-title":"Goserelin","volume":"51","author":"Perry","year":"1996","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD010854.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpobgyn.2008.03.001","article-title":"Medical management of fibroids","volume":"22","author":"Sankaran","year":"2008","journal-title":"Best Practice & Research. Clinical Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD010854.pub2-BIB0054|cit54","first-page":"856","article-title":"A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata","volume":"74","author":"Schlaff","year":"1989","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD010854.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(72)90015-7","article-title":"Quantitation of menstrual blood loss\u2014further evaluation of the alkaline hematin method","volume":"5","author":"Shaw","year":"1972","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD010854.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/humrep\/dep396","article-title":"The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis","volume":"25","author":"Sunkara","year":"2010","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0057|cit57","first-page":"431","article-title":"Self-reported heavy bleeding associated with uterine leiomyomata","volume":"101","author":"Wegienka","year":"2003","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010854.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0028-2243(90)90014-R","article-title":"Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging","volume":"34","author":"Williams","year":"1990","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010854.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T09:42:31Z","timestamp":1721122951000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010854.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010854.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725398736.793539262","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}